AAAAAA
Results:
1-11
|
Results: 11
Authors:
DENARDO SJ
KROGER LA
MACKENZIE MR
MIRICK GR
SHEN S
DENARDO GL
Citation: Sj. Denardo et al., PROLONGED SURVIVAL ASSOCIATED WITH IMMUNE-RESPONSE IN A PATIENT TREATED WITH LYM-1 MOUSE MONOCLONAL-ANTIBODY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 1-12
Authors:
ODONNELL RT
DENARDO SJ
SHI XB
MIRICK GR
DENARDO GL
KROGER LA
MEYERS FJ
Citation: Rt. Odonnell et al., L6 MONOCLONAL-ANTIBODY BINDS PROSTATE-CANCER, The Prostate, 37(2), 1998, pp. 91-97
Authors:
DENARDO GL
DENARDO SJ
KUKIS DL
ODONNELL RT
SHEN S
GOLDSTEIN DS
KROGER LA
SALAKO Q
DENARDO DA
MIRICK GR
MAUSNER LF
SRIVASTAVA SC
MEARES CF
Citation: Gl. Denardo et al., MAXIMUM TOLERATED DOSE OF CU-67-2IT-BAT-LYM-1 FOR FRACTIONATED RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA - A PILOT-STUDY, Anticancer research, 18(4B), 1998, pp. 2779-2788
Authors:
DENARDO GL
DENARDO SJ
DENARDO DA
SHEN S
MIRICK GR
MACEY DJ
LAMBORN KR
Citation: Gl. Denardo et al., FACTORS AFFECTING I-131 LYM-1 PHARMACOKINETICS AND RADIATION-DOSIMETRY IN PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) AND CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), The Journal of nuclear medicine, 39(5), 1998, pp. 438-438
Authors:
DENARDO GL
MIRICK GR
ODONNELL RT
KROGER LA
MIERS LA
DENARDO SJ
Citation: Gl. Denardo et al., PROLONGED SURVIVAL AND CYTOTOXIC - NHL SPECIFIC ANTIBODIES IN A PATIENT TREATED WITH I-131 LYM-1 MOUSE MONOCLONAL-ANTIBODY, The Journal of nuclear medicine, 39(5), 1998, pp. 1179-1179
Authors:
DENARDO GL
MIRICK GR
KROGER LA
ODONNELL RT
MEARES CF
DENARDO SJ
Citation: Gl. Denardo et al., ANTIBODY-RESPONSES TO MACROCYCLES IN LYMPHOMA, The Journal of nuclear medicine, 37(3), 1996, pp. 451-456
Authors:
KUKIS DL
DENARDO GL
DENARDO SJ
MIRICK GR
MIERS LA
GREINER DP
MEARES CF
Citation: Dl. Kukis et al., EFFECT OF THE EXTENT OF CHELATE SUBSTITUTION ON THE IMMUNOREACTIVITY AND BIODISTRIBUTION OF 2IT-BAT-LYM-1 IMMUNOCONJUGATES, Cancer research, 55(4), 1995, pp. 878-884
Authors:
KUKIS DL
DENARDO SJ
DENARDO GL
GREINER DP
SALAKO QA
MIRICK GR
MEARES CF
Citation: Dl. Kukis et al., EFFECT OF THE EXTENT OF SUBSTITUTION ON THE IMMUNOREACTIVITY OF 2IT-BAT-LYM-1 IMMUNOCONJUGATE, The Journal of nuclear medicine, 35(5), 1994, pp. 160000259-160000259
Authors:
DENARDO SJ
MIRICK GR
KROGER LA
OGRADY LF
ERICKSON KL
YUAN A
LAMBORN KR
HELLSTROM I
HELLSTROM KE
DENARDO GL
Citation: Sj. Denardo et al., THE BIOLOGIC WINDOW FOR CHIMERIC L6 RADIOIMMUNOTHERAPY, Cancer, 73(3), 1994, pp. 1023-1032
Authors:
DENARDO SJ
MIRICK GR
KROGER LA
OGRADY LF
ERICKSON KL
YUAN A
HELLSTROM I
HELLSTROM KE
DENARDO GL
Citation: Sj. Denardo et al., BIOLOGIC ENHANCEMENT OF CHL6 RADIOIMMUNOTHERAPY SHOWN BY CORRELATION OF EFFECTOR CELL, COMPLEMENT AND LYMPHOKINE ACTIVATION WITH THERAPEUTIC EFFECTS, The Journal of nuclear medicine, 34(5), 1993, pp. 93-94
Authors:
DENARDO GL
MAHE MA
DENARDO SJ
MACEY DJ
MIRICK GR
ERWIN WD
GROCH MW
Citation: Gl. Denardo et al., BODY AND BLOOD CLEARANCE AND MARROW RADIATION-DOSE OF I-131 LYM-1 IN PATIENTS WITH B-CELL MALIGNANCIES, Nuclear medicine communications, 14(7), 1993, pp. 587-595
Risultati:
1-11
|